Larvol Delta - Ampio-Announces-Enrollment-Completion-for-Intravenous-IV-COVID19-Clinical-Trial-amp-Provides-Update-on-Osteoarthritis-of-the-Knee-OAK-Clinical-Trial

Ampion IV (diketopiperazine) - Ampio

https://www.prnewswire.com/news-releases/ampio-announces-enrollment-completion-for-intravenous-iv-covid-19-clinical-trial--provides-update-on-osteoarthritis-of-the-knee-oak-clinical-trial-301124360.html

Sep 4, 2020

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next